An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Mansoura university, Mansourah, Dakahlia, Egypt
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
UMCLjubljana, CD of Anaesthesiology and Intensive Therapy, Ljubljana, Slovenia
Kyiv Clinical City Hospital #1, Kyiv, Ukraine
Assiut University Hospital, Assiut, Egypt
Sultan Keles, Aydın, Efeler, Turkey
Assiut university, Assiut, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.